[
    "{\"step_by_step_thinking\": \"To determine if major brain gangliosides are a target for the treatment of Alzheimer's disease as of Feb 2019, we need to analyze the relevant documents. Document [3] states that gangliosides, including GM1-ganglioside, have been applied for the treatment of CNS injuries and diseases, including Alzheimer's disease. Document [6] mentions that gangliosides, such as GM1, are highlighted as a potential target for the treatment of Alzheimer's disease. Document [12] also suggests that gangliosides, including GM1, may have a therapeutic role in Alzheimer's disease. Based on this information, it can be concluded that as of Feb 2019, major brain gangliosides are indeed a target for the treatment of Alzheimer's disease.\", \"answer_choice\": \"A\"}"
]